Oshimura M, Ohyashiki K, Terada H, Takaku F, Tonomura A
Cancer Genet Cytogenet. 1982 Mar;5(3):187-201. doi: 10.1016/0165-4608(82)90025-5.
A serial cytogenetic study of 110 cases of chronic myelogenous leukemia (CML) has been performed with G- and/or Q-banding techniques with the following results. (1) Seven out of the 110 cases were karyotypically normal. (2) A variant Ph1 translocation was observed in three cases. In one case, the leukemic cells contained two reciprocal translocations, i.e., a t(3;9) (q21;q34) and a t(17;22)(q21;q11); therefore, a Ph1 chromosome was masked by a translocation of the deleted material from the 17q onto the band q11 of the long arm of a chromosome No. 22. In the second case, a variant Ph1 translocation involved chromosomes No. 9, 20, and 22, resulting in a karyotype interpreted as 46,XX,t(9q+;20q+;22q-); in this rearrangement, one of the segments, i.e., 9q31 or 9q33, seemed to be interstitially deleted and inserted into the interstitial region (q11) of a chromosome No. 20 and the 22q11 leads to qter was translocated onto the 9q. This is the first case in which chromosome No. 20 was involved in a variant Ph1 translocation. In the third case, the karyotype of leukemic cells was interpreted as 46,XX,t(5;9;22)(q13;q34;q11). (3) The frequency of Ph1-negative CML and that of Ph1-positive CML with various types of Ph1 translocation from 15 studies reported as series of 25 or more cases, including the present study, have been tabulated. The incidence of a variant Ph1 translocation was 4.1% (42/1027 cases of Ph1-positive CML); of the 42, 13 were of a simple type and 29 of a complex type. (4) In one case of the present study, a masked Ph1 by a translocation of material onto the short arm of the 22q- was observed in the blastic crisis but not in the chronic phase. From the present study and a review of the published cases, it appears that the incidence of such a "masked" Ph1, which cannot be detected by conventional Giemsa staining, is less than 0.6% in CML cases. (5) The first and the second cases with a variant Ph1 translocation mentioned above developed a myeloid blastic crisis after the induction of remission of a lymphoid blastic crisis. For the present, it is unclear whether the occurrence of such blast cells in the two cases and the cytogenetic findings are coincidental. However, the evidence supports the notion of "lymphoid-myeloid" multipotentiality of certain leukemic cells.
采用G带和/或Q带技术对110例慢性粒细胞白血病(CML)患者进行了系列细胞遗传学研究,结果如下:(1)110例患者中7例核型正常。(2)3例观察到变异型Ph1易位。1例患者的白血病细胞含有两个相互易位,即t(3;9)(q21;q34)和t(17;22)(q21;q11);因此,Ph1染色体被从17q缺失的物质易位到22号染色体长臂q11带所掩盖。第2例患者,变异型Ph1易位涉及9号、20号和22号染色体,核型解释为46,XX,t(9q+;20q+;22q-);在这种重排中,其中一个片段,即9q31或9q33,似乎发生了中间缺失并插入到20号染色体的中间区域(q11),22q11至qter易位到9q上。这是20号染色体参与变异型Ph1易位的首例病例。第3例患者,白血病细胞核型解释为46,XX,t(5;9;22)(q13;q34;q11)。(3)汇总了包括本研究在内的15项报告病例数为25例或更多的研究中Ph1阴性CML以及具有各种类型Ph1易位的Ph1阳性CML的发生率。变异型Ph1易位的发生率为4.1%(1027例Ph1阳性CML患者中的42例);42例中,13例为简单型,29例为复杂型。(4)本研究中的1例患者在急变期观察到因物质易位到22q-短臂而导致的隐匿性Ph1,而在慢性期未观察到。根据本研究及已发表病例的回顾,似乎这种常规吉姆萨染色无法检测到的“隐匿性”Ph1在CML病例中的发生率低于0.6%。(5)上述两例变异型Ph1易位患者在淋巴细胞母细胞危象诱导缓解后发生了髓细胞母细胞危象。目前尚不清楚这两例中此类母细胞的出现与细胞遗传学发现是否巧合。然而,证据支持某些白血病细胞具有“淋巴细胞-髓细胞”多能性的观点。